Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1315 of 5804
-
New combo aims to boost stem cell transplant success in older myeloma patients
Disease control Recruiting nowThe purpose of this study is to see if siltuximab plus population pharmacokinetic (PK)-dosed melphalan works as well as the usual approach (body surface area \[BSA\]-dosed melphalan) in people with multiple myeloma (MM) who are receiving an autologous stem cell transplant (ASCT) …
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New balloon catheter zaps heart rhythm problem in early trial
Disease control OngoingThis clinical trial aims to evaluate the safety and effectiveness of pulmonary vein isolation (PVI) and linear ablation using a large-focal pulsed field ablation (PFA) catheter in patients with persistent atrial fibrillation (perAF). The study will address two primary questions: …
Phase: NA • Sponsor: The Third People's Hospital of Chengdu • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
One-Day liver cancer treatment could cut hospital time in half
Disease control ENROLLING_BY_INVITATIONThis single-arm feasibility study evaluating the safety and efficacy of streamlining Yttrium-90 (Y90) radioembolization workflow for patients with small Hepatocellular Carcinoma (\<5cm) that have no aggressive features on baseline imaging. This study aims to recruit N=30 patie…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for kids with rare bleeding disorder: drug aims to stop bleeds before they start
Disease control Recruiting nowThe main aim of the study is to evaluate the effectiveness of prophylaxis with vonicog alfa (recombinant von Willebrand factor \[rVWF\]) in children. This study will enroll those participants who have been previously treated with VWF product or with a plasma-derived VWF (pdVWF) p…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New wire device aims to unclog leg arteries without surgery
Disease control Recruiting nowThis study is to assess the safety and efficacy of the FastWire System. It is intended to assess that the FastWire System can facilitate the intra-luminal placement of conventional guidewires or treatment devices beyond peripheral artery chronic total occlusions (CTOs)
Phase: NA • Sponsor: Versono Medical Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Bladder cancer breakthrough? new drug combo aims to stop tumors returning
Disease control Recruiting nowBladder cancer is the 8th most common cancer in the UF Health Cancer Center catchment area and the 7th most common cancer presenting to UFHealth. Most newly diagnosed cases are stage I bladder cancer, which is defined by having no deep muscle invasion and no evidence of disease b…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for kids with rare sanfilippo syndrome? early trial launches
Disease control Recruiting nowA Phase I/ II, open-label study, designed to evaluate the safety and explore efficacy of the study drug in development for the treatment of MPS IIIB patients.
Phase: PHASE1, PHASE2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:37 UTC
-
Virus therapy takes on bladder cancer in early trial
Disease control Recruiting nowRecombinant oncolytic adenovirus injection (KD01) is an oncolytic virus product. Its main component is a conditionally replicative recombinant human type 5 adenovirus, where part of the E3 region has been replaced with the gene encoding the tBid apoptotic protein.AK104 is a human…
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New injection shows promise for dialysis patients with hormone imbalance
Disease control CompletedThis is a randomized, positive controlled, and placebo-controlled phase II clinical study to evaluate the efficacy and safety of MT1013 injection in the treatment of chronic kidney disease with secondary hyperparathyroidism (SHPT) undergoing maintenance hemodialysis (MHD) subject…
Phase: PHASE2 • Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New antibody therapy tested for long-term safety in immune-deficient patients
Disease control OngoingThe main aim of this study is to learn if TAK-881 is safe and well tolerated during long-term use in adults and children with PIDD who are eligible and completed study TAK-881-3001 (NCT05755035). The participants will receive the first dose of TAK-881 immunoglobulin (IgG) infusi…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a 5-Day proton blast beat prostate cancer for good?
Disease control Recruiting nowThe goal of this prospective observational cohort study is to evaluate the long-term efficacy and safety of ultrahypofractionated proton beam therapy in patients with localized prostate cancer and to identify clinical and treatment-related factors associated with oncologic outcom…
Phase: NA • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can standing orders get more teens vaccinated against HPV?
Prevention Recruiting nowEach year in the U.S., ≥20,000 women and 14,000 men are affected by HPV-related cancers, including cervical and oropharyngeal cancer. However, in 2020, only 59% of U.S. adolescents aged 13-17 were up-to-date for HPV vaccination, and rates for 11-12 year olds, the primary target a…
Phase: NA • Sponsor: University of Rochester • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New Vaccine-Drug combo targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis is a pilot study to determine feasibility and safety of the combination of Dendritic Cell (DC1) vaccines and elacestrant in patients with hormone positive HER2 negative metastatic breast cancer.
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New 8-Question test could slash autism diagnosis wait times for adults
Diagnosis Recruiting nowTo improve diagnosis of Autism Spectrum Disorder (ASD), expert centers have been set up in France since 2000/2010. However, waiting times in these centers are long, mean of 19 months for adults, and more than half the people seen do not end up with an ASD, even though referral by…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New stimulation combo aims to restore movement in spinal cord injury
Symptom relief Recruiting nowThe purpose of this research is to explore the effect of magnetic stimulation to activate the brain, electrical spinal cord stimulation to activate spinal cord, and electrical muscle stimulation used to activate upper limb (arms), lower limb (legs) and trunk (stomach) muscles in …
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New approach boosts RSV shots in pregnancy to shield babies
Prevention CompletedCentral hypothesis: a multimodal approach is needed to enhance RSV vaccine uptake in pregnancy rather than the current standard of care that relies solely on physician recommendations at routine prenatal visits and/or mass messaging to the public. The investigators propose a pilo…
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Super flu shot for middle-aged adults? new study shows promise
Prevention CompletedThe purpose of this study is to evaluate Immunogenicity and Safety of a High-Dose (HD) Influenza Vaccine (IV) in Adults 50 through 64 Years of Age.
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Time-Restricted eating may beat cancer fatigue, new study hopes
Symptom relief Recruiting nowCancer-related fatigue affects at least 30-90% of patients with cancer, depending on the type of cancer and their treatment(s) (e.g., chemotherapy, radiation). It is not relieved by sleep or rest, and it sometimes can persist for years after a person's cancer was treated. The fat…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
AI boosts colonoscopy accuracy for lynch syndrome patients?
Diagnosis CompletedWe aim to investigate the incremental detection rate of polyps using AI- assisted colonoscopy compared with high-definition white-light endoscopy (HD-WLE). We will conduct a single-center randomized tandem colonoscopy trial of patients with Lynch syndrome with and without AI. Pa…
Phase: NA • Sponsor: Sheba Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
New combo aims to tackle myeloma and kidney failure at once
Disease control Recruiting nowThe goal of this study is to assess the efficacy of induction treatment with daratumumab-hyaluronidase (dara SC) with cyclophosphamide, bortezomib, and dexamethasone (Dara-CyBorD) for four cycles in patients with newly diagnosed multiple myeloma who have new onset renal failure. …
Phase: EARLY_PHASE1 • Sponsor: Augusta University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC